Samsara Bio Capital, LLC Forma Therapeutics Holdings, Inc. Transaction History

Samsara Bio Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $3.56 Million - $10.1 Million	-500,113 Reduced 31.95%	1,065,413 $21.3 Million
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $63 - $77	-3 Reduced -0.0%	1,565,526 $36.3 Million
Q1 2021 May 18, 2021	BUY	$24.58 - $42.82 $3.61 Million - $6.29 Million	147,000 Added 10.36%	1,565,529 $43.9 Million
Q4 2020 Feb 17, 2021	SELL	$34.9 - $51.08 $2.57 Million - $3.76 Million	-73,634 Reduced 4.93%	1,418,529 $49.5 Million
Q3 2020 Nov 16, 2020	SELL	$32.95 - $50.25 $2.84 Million - $4.33 Million	-86,225 Reduced 5.46%	1,492,163 $74.4 Million
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $61.6 Million - $73.4 Million	1,578,388 New	1,578,388 $73.4 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.